|
HS Code |
416239 |
| Chemical Name | Di-Tert-Butyl N,N-Diethylphosphoramidite |
| Cas Number | 85283-12-1 |
| Molecular Formula | C12H28NO2P |
| Molecular Weight | 249.33 |
| Appearance | Colorless to pale yellow liquid |
| Purity | Typically ≥ 97% |
| Boiling Point | 151-153 °C (15 mmHg) |
| Density | 0.95 g/mL at 25 °C |
| Solubility | Soluble in organic solvents (e.g., dichloromethane, acetonitrile) |
| Storage Conditions | Store under inert gas, at 2-8 °C |
| Application | Used in oligonucleotide synthesis as a phosphitylating reagent |
| Synonyms | N,N-Diethyl di-tert-butylphosphoramidite |
As an accredited Di-Tert-Butyl N,N-Diethylphosphoramidite factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Di-Tert-Butyl N,N-Diethylphosphoramidite is supplied in a 25g amber glass bottle with a tight-seal cap and safety labeling. |
| Shipping | Di-Tert-Butyl N,N-Diethylphosphoramidite is typically shipped in sealed, airtight containers under an inert gas, such as nitrogen, to prevent hydrolysis and oxidation. The package is clearly labeled as a moisture-sensitive, air-sensitive, and possibly flammable chemical, and is transported following relevant chemical safety regulations. |
| Storage | **Di-Tert-Butyl N,N-Diethylphosphoramidite** should be stored under an inert atmosphere, such as nitrogen or argon, in a tightly sealed container. It must be kept in a cool, dry place, away from moisture, air, and sources of ignition. Store at 2–8°C (refrigerated), and protect from light. Handle only in a well-ventilated area with appropriate precautions and personal protective equipment. |
Applications of Di-Tert-Butyl N,N-Diethylphosphoramidite in Industrial ManufacturingDi-Tert-Butyl N,N-Diethylphosphoramidite is widely utilized as a specialized organophosphorus reagent in demanding fine chemical and pharmaceutical manufacturing processes. Our production ensures stable, low-water content and consistent batch quality, supporting critical applications that require highly selective phosphorus transfer and precise reactivity control. Below, we detail the material’s roles in essential downstream segments, with a focus on practical industrial scenarios. 1. Oligonucleotide Synthesis for Active Pharmaceutical IngredientsThis phosphoramidite compound plays a central role as a monomer in automated solid-phase synthesis of DNA and RNA analogues required for antisense drugs, mRNA vaccines, and gene therapeutics. Downstream users rely on high-purity input to maximize yield, minimize failure sequences, and achieve stringent impurity profiles demanded by regulatory filings. Precise addition during chain elongation determines the final oligonucleotide quality for clinical and commercial batch production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Nucleotide Prodrugs for Direct-Acting AntiviralsManufacturers of nucleotide analogue prodrugs—such as those targeting hepatitis C virus—deploy this phosphoramidite for introducing protected phosphorus groups required for stepwise construction of complex prodrug structures. Its use in organophosphorus coupling reactions ensures precise modification and effective scale-up for regulatory submissions, impacting both yield and pharmacological profile of the prodrug. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Ligand Synthesis for Metal-Catalyzed Organic ReactionsOur chemical is integrated as a phosphorus source during the synthesis of specialty ligands, including phosphoramidite and phosphite types used in asymmetric hydrogenation, cross-coupling, and fine chemical catalysis. Strict organometallic process controls and impurity management enable downstream users to reliably produce advanced catalysts for industrial reaction platforms, affecting product selectivity and process economics. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Intermediates for Agrochemical SynthesisAgrochemical process design often requires phosphorus reagents for constructing key intermediates such as phosphonamidates and phosphoramidates used in crop protection products. This material's bulky tert-butyl groups impart beneficial steric effects, assisting controlled coupling and improved selectivity during phosphoramidite-mediated steps in herbicide and insecticide synthesis pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Synthesis of Modified Nucleosides for Life Science ReagentsLife science reagent manufacturers incorporate this reagent during the phosphitylation and protection of nucleoside and nucleotide analogues for research kits and analytical standards. High reactivity and low residual water support the reproducibility required for diagnostic-grade reagents, while scalability matches commercial batch sizes for global kit suppliers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Di-Tert-Butyl N,N-Diethylphosphoramidite prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Countless hours in chemical development have taught us that small changes in structure sometimes make the difference between reliable synthesis and frustrating side reactions. Di-Tert-Butyl N,N-Diethylphosphoramidite stands as one of those compounds that rewards experimental patience and delivers valuable results. Our years of work at the bench and in upgrading large-scale reactors provide an honest window into what this phosphoramidite does best and why production methods and choices around it matter so much for users with no room for error.
For more than twenty years, our approach to phosphorus chemistry evolved from careful pilot batches in glass to advanced automated synthesis lines. We produce Di-Tert-Butyl N,N-Diethylphosphoramidite under inert conditions, taking extreme care to control moisture levels, oxygen ingress, and temperature swings. Each stage goes under constant testing, not just for yield, but to prevent formation of by-products that can sabotage delicate oligonucleotide coupling reactions.
Phosphoramidites like this one are sensitive to hydrolysis. From our earliest days we learned the hard way—the faintest trace of water triggers decomposition, wastes expensive starting materials, and bogs down purification. For production, we use rigorous drying cycles and glovebox transfer, not just to say we offer “high-purity material,” but because we fought for that reliability in repeat batch work with some of the world’s most measured process development scientists.
Di-Tert-Butyl N,N-Diethylphosphoramidite bears significant structural distinctions from more common analogs like diisopropyl phosphoramidites. The presence of two tert-butyl groups at phosphorus gives a noticeable bulking effect, increasing the compound’s steric protection during phosphorus(III) transfer reactions. This change, slight as it may look, influences both base-catalyzed and acid-catalyzed environments. With diethyl groups on the nitrogen atom, this phosphoramidite resists side reactions and salt formation better than many similar reagents.
We have run multi-year studies comparing this molecule to diisopropyl analogs, both as a core building block in nucleic acid chemistry and as a ligand precursor. In large-scale DNA synthesis projects, we observed that these bulky tert-butyl groups suppress unwanted branching and preserve the purity of the product through repeated cycles. In ligation reactions using sensitive aldehydes or electrophiles, the distinct reactivity profile cut down on cleanup steps and made downstream purification more straightforward.
Development chemists demand reproducible coupling efficiency if they want to scale their processes. Di-Tert-Butyl N,N-Diethylphosphoramidite delivers in two key settings: oligonucleotide assembly and as a versatile chemical intermediate. Peptide chemists who tried every other phosphoramidite on the market repeatedly reached out to us after fighting with phosphite triesters that hydrolyze halfway through the assembly. In our hands, and with our support, they replaced problematic amidites with the tert-butyl diethyl variant and saw batch rejections drop.
DNA synthesizer manufacturers ask for standardized lots. Our experience in drying, packaging, and tight lot-to-lot reproducibility comes directly from seeing where things go wrong—down to the ppm of water in the final product. Product managers want to avoid headaches from stalled syntheses caused by impurity spikes; our batch records reflect the extra effort to requalify starting materials and raw solvents. Sourcing specialists know that a stream of incident-free shipments matters more than the most dazzling spec sheet: we have fielded late-night phone calls when a shipment elsewhere turned out off-spec, and we delivered emergency replacements that solved critical run interruptions.
We formulated the Di-Tert-Butyl N,N-Diethylphosphoramidite under dry, oxygen-free argon, distilling all reactants before transfer and running a batch-specific Karl Fischer titration at multiple stages. Setting up TGA and DSC to cross-check thermal decomposition helped us fine-tune both shipping and storage protocols. Independent labs validate batch GC and NMR, because customers ordering by the kilo count on the data matching what really goes into the bottle.
A common question we face: what shelf life does this compound support? In an ideal world, everything ships and gets used in two weeks. In reality, procurement miscalculations and project delays happen. We stability-tested our product for months in ampoules and specialty vials, and monitored key signals for degradation by NMR and GC-MS. The data gave us confidence to recommend real-life handling, not just idealized protocols. This insight shaped our advice to clients, from lab-scale to pilot plant, answering direct concerns about batch storage, shipping in extreme weather, and re-testing after prolonged warehouse stints.
Many chemists ask us how it compares with diisopropyl or diphenyl variants. In side-by-side coupling reactions for nucleic acid synthesis, the tert-butyl diethyl version delivered higher yields in high-throughput machines. The reason traced back to blocked side-reactions, something our QC team picks up often on analytical traces.
We ran unrestricted head-to-head trials with several research and pharmaceutical partners who had tried every variation—diisopropyl, di-n-butyl, mixed-substituent analogs. The tert-butyl groups lowered room-temperature air sensitivity, which translated to less breakdown in semi-automated production lines. Monitoring both main phosphoramidite consumption and by-product formation, the data tipped in favor of this bulkier variant for higher molecular weight oligonucleotides and advanced chemical ligands.
Nearly all new customers cite nucleic acid chemistry as their main interest, often in the synthesis of phosphoramidite-blocked building blocks for solid-phase assembly. We have watched as a new wave of chemical biologists began using our material in site-specific modification projects: attaching fluorescent tags, introducing phosphate analogs, or building bridge linkages never seen before in natural DNA or RNA. As bioconjugation branched out from biomedical to agricultural and materials science, our product found new utility in non-nucleotide frameworks where its unique substitution pattern directed selective transformation and protected critical functionality.
This kind of feedback from end users, some working at startup scale, others in major global pharmaceutical houses, reached us directly through shared protocols and troubleshooting discussions. Synthetic teams reported that the increased steric bulkers of our phosphoramidite sometimes allowed successful coupling of "difficult" sequences or modifications that repeatedly failed with lighter, more reactive variants.
Years in chemical manufacturing taught us that customers prize reliability more than theoretical metrics. As the original manufacturer—not a reseller or repacker—we control every step, from handling raw phosphorus trichloride, to in-house distillation of chlorinating agents, through to inert atmosphere bottling. Each drum and bottle comes from a batch run under our direct oversight, tested with the same eyes that check our pilot-scale intermediates for commercial drug manufacturing.
We invest in maintaining a closed reliability loop: we know if a solvent drum doesn’t match water content specs long before raw materials enter the reactor. Each batch undergoes complete audit trail verification, so that our partners—be they process chemists, cartridge packers, or integrators of automated DNA synthesizers—never face guessing games.
Shipping moisture and air sensitive phosphoramidites to five continents opened our eyes a decade ago. We learned fast that even a few hours outside a dry box could impact air-stable analogs, and that buffer-packaging these amidites without proper desiccants led to costly returns. We moved to heavy-walled amber glass with a specialized liner and integrated moisture trap technology; the packaging lines run contiguous to QC and final product storage, with humidity barriers monitored in real time.
For urgent deliveries and routine restocking, our teams field-test every batch across a range of climates and customs scenarios. Key accounts—especially new high-throughput RNA/DNA manufacturing clients—require highly time-sensitive shipments. We instituted redundant cooling and expedited supply chains, after hearing from partners who suffered project delays with other suppliers due to subpar logistics.
Credibility comes from solving problems that chemists run into, not theory. We respond daily to technical questions about compatibility with specific linkers, solid supports, and downstream processing agents. We have seen poorly characterized phosphoramidites lead to unexplained failures in long oligonucleotide assemblies and responded by sharing our in-house process adjustment logs to aid users troubleshooting product stability and reaction conditions.
Partnering with groups scaling to the kilogram level, we saw joint troubleshooting on stuck pumps and packed columns when impurities built up faster than expected. Our collaborative experience enabled us to provide working solutions—whether that meant on-the-fly changes in the protection/deprotection cycle or detailed impurity mapping with state-of-the-art mass spec equipment. This commitment underpins our readiness to pull reports and operational logs when partners run into process bottlenecks.
From our earliest forays into phosphorus chemistry, we understood that rigorous safety processes protect both our workers and our customers. With a compound this sensitive to moisture and air, every batch is handled in full compliance with relevant regulations and under internal safety protocols exceeding basic requirements. Workers receive ongoing training in handling pyrophoric agents and following proper neutralization and waste disposal routines.
Our technical team participates in continuous dialogues with health and safety inspectors, cross-referencing material safety data with the latest academic findings and regulatory requirements. We don’t outsource this responsibility; our credibility rests on open-door inspections and unannounced batch audits, which help us anticipate regulatory changes before they become bottlenecks for customers down the line.
Five-gram orders once set the standard—today we routinely fulfill kilo-level lots for university programs running combinatorial chemical libraries or high-throughput gene synthesis labs. Fast turnaround on custom batch sizes, with rapid switching between production scales, grew from our investment in flexible, segmented reactor trains. Both start-ups and established research organizations push us to innovate with new derivatives and custom-tailored phosphoramidites. We devote real time to feedback calls and pilot projects, prototyping everything from alternative N-substituents to novel P-protecting groups.
Every successful delivery builds towards higher-throughput and improved performance for customers developing vaccines, diagnostics, and next-generation materials. We refine our product lines not by press release but through iterative work with industry labs, watching which innovations become industry standards and which fade away due to practical hurdles.
Pattern recognition is easier after years around process engineers and project leads struggling with real-life deadlines and budgets. The shift towards custom oligonucleotide-based therapeutics and diagnostic tools demands building blocks that simply work as intended—with no hidden instability or batch-to-batch drift. Our team hears the urgency in the voice of the clinical and discovery scientists who rely on a phosphoramidite that delivers at every phase, from screening runs to GMP batch support.
Our experience put us in a unique position to advise scientists tackling new chemical modifications, whether extending nucleic acid strands, building site-specifically labeled molecules for diagnostics, or exploring therapeutic conjugates that depend on precisely installed phosphorous chemistry. We draw on evidence from repeated, real-world validations, knowing that project delays, regulatory scrutiny, and final drug approval depend on the integrity of each chemical transformation.
Chemical manufacturing is a live sport, not a set of static rules. The challenges behind every “simple” bottle of Di-Tert-Butyl N,N-Diethylphosphoramidite taught us that continuous learning, hands-on quality control, and rapid troubleshooting keep products meeting stringent project needs. Our team makes sure each batch reflects the best current practice, not yesterday’s shortcut or outsourced method.
Listening to project chemists, process engineers, and research directors guides our process development roadmaps. We welcome those hard calls: “This worked in a paper, but not in my plant—why?” Honest assessment and technical transparency translate into easier reactions, more predictable yields, and faster project milestones for those working at the sharp end of chemical development.
Our door remains open to those ready to push the boundaries of synthetic chemistry. Every request, every technical challenge, and every batch feedback loop shapes the ongoing evolution of Di-Tert-Butyl N,N-Diethylphosphoramidite from theory to trusted tool. Our promise is grounded in the practical, everyday reality of the chemists who rely on us—and on this unique phosphoramidite—to deliver the next wave of scientific advancement.